Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 4/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.44 |
| ▸ | BACE1 | P56817 | 4/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.41 |
| ▸ | GAA | P10253 | 3/20 | 0.41 |
| ▸ | MEN1 | O00255 | 3/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.41 |
| ▸ | MAPT | P10636 | 3/20 | 0.41 |
| ▸ | PKM | P14618 | 2/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | APEX1 | P27695 | 2/20 | 0.41 |
| ▸ | RECQL | P46063 | 2/20 | 0.41 |
| ▸ | ALPL | P05186 | 2/20 | 0.41 |
| ▸ | POLB | P06746 | 2/20 | 0.41 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.41 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.41 |
| ▸ | APP | P05067 | 2/20 | 0.41 |
| ▸ | AMY1A | P0DUB6 | 1/20 | 0.41 |
| ▸ | ALPG | P10696 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15450263 | 1.00 | CYP3A4 (0.44) | CYP3A4MAPK1BACE1KDM4EGAA | |
| SCHEMBL15450266 | 1.00 | CYP3A4 (0.44) | CYP3A4MAPK1BACE1KDM4EGAA | |
| SCHEMBL15450257 | 1.00 | CYP3A4 (0.44) | CYP3A4MAPK1BACE1KDM4EGAA | |
| SCHEMBL17358249 | 0.93 | CYP3A4 (0.43) | CYP3A4MAPK1BACE1KDM4EGAA | |
| SCHEMBL17523259 | 0.91 | CYP3A4 (0.42) | CYP3A4MAPK1BACE1KDM4EGAA | |
| SCHEMBL17523257 | 0.91 | CYP3A4 (0.42) | CYP3A4MAPK1BACE1KDM4EGAA | |
| SCHEMBL17358243 | 0.90 | KDM4E (0.56) | CYP3A4MAPK1BACE1KDM4EGAA | |
| SCHEMBL10016120 | 0.89 | STING1 (0.46) | CYP3A4MAPK1BACE1KDM4EMEN1 | |
| SCHEMBL24983638 | 0.88 | CYP3A4 (0.50) | CYP3A4MAPK1BACE1KDM4EGAA | |
| SCHEMBL13507373 | 0.88 | CYP3A4 (0.50) | CYP3A4MAPK1BACE1KDM4EGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9975869-B2 | Analogues of epicatechin and related polyphenols | SPHAERA PHARMA PVT. LTD. (IN) | 2018-05-22 | — | — | US | disclosed |
| US-9556140-B2 | Approach for synthesis of catechins | SPHAERA PHARMA PVT. LTD. (IN) | 2017-01-31 | — | — | US | disclosed |
| US-20160039781-A1 | NOVEL ANALOGUES OF EPICATECHIN AND RELATED POLYPHENOLS | SPHAERA PHARMA PVT. LTD. (SG) | 2016-02-11 | — | — | US | disclosed |
| US-20150368223-A1 | NOVEL APPROACH FOR SYNTHESIS OF CATECHINS | EPIRIUM BIO INC. | 2015-12-24 | — | — | US | disclosed |
| US-9187448-B2 | Flavonoid compounds | CARDERO THERAPEUTICS, INC. (US) | 2015-11-17 | — | — | US | disclosed |
| US-20140256741-A1 | FLAVONOID COMPOUNDS | CARDERO THERAPEUTICS, INC. (US) | 2014-09-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140256741-A1 | FLAVONOID COMPOUNDS | FIS1, TFAM, MFN2 | CYP3A4 3740/4885MAPK1 943/4885BACE1 4428/4885 |
| US-20150368223-A1 | NOVEL APPROACH FOR SYNTHESIS OF CATECHINS | NQO1, COMT, NNMT | CYP3A4 144/4885MAPK1 2894/4885BACE1 1434/4885 |
| US-20160039781-A1 | NOVEL ANALOGUES OF EPICATECHIN AND RELATED POLYPHENOLS | PGC, TEAD3, TEAD4 | CYP3A4 518/4885MAPK1 2613/4885BACE1 4245/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.